Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus

A Single Center Open-label Randomized Control Pilot Study to Assess the Efficacy of Real-time Continuous Glucose Monitoring in Subjects With Gestational Diabetes to Increase Glucose Time-in-range

The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes

Inclusion Criteria:

• Age 18-55 years
• Singleton pregnancy ≥20 weeks gestation
• Diagnosed with GDM by either 1-step (IADPSG) or 2-Step (Carpenter-Coustan)
• Compatible, validated phone and operating system to support Dexcom G6 CGM App (See Supplementary Table 1) or option to use receiver

Exclusion Criteria:

• Chronic immunosuppression
• Concomitant disease or condition that may compromise patient safety or the ability to complete study tasks including and not limited to: severe mental illness or a diagnosed or suspected eating disorder
• Known allergy to medical grade adhesives
• Pre-gestational diabetes
• Multifetal gestation
• Current alcohol or illicit drug use
• Simultaneous participation in another clinical study with investigational medicinal product(s) that might have an impact on the study objectives.